SCHEMBL5067922

SCHEMBL5067922

CCOC(=O)[C@@H](CC(=O)c1ccc(-c2ccc([N+](=O)[O-])cc2)cc1)Cc1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.55
MEN1 O00255 2/20 0.55
KMT2A Q03164 2/20 0.55
TP53 P04637 1/20 0.49
RAB9A P51151 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
ALDH1A1 P00352 1/20 0.48
MAPT P10636 1/20 0.48
POLB P06746 1/20 0.47
MAPK1 P28482 1/20 0.47
AR P10275 5/20 0.47
EPHX2 P34913 1/20 0.47
PPARG P37231 1/20 0.47
PGR P06401 2/20 0.45
ALOX5 P09917 1/20 0.45
CRHBP P24387 1/20 0.43
CRHR2 Q13324 1/20 0.43
CPA1 P15085 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4235715 1.00 NPC1 (0.55) NPC1MEN1KMT2ATP53RAB9A
SCHEMBL1747949 0.89 NPC1 (0.53) NPC1MEN1KMT2ATP53RAB9A
SCHEMBL6031308 0.89 NPC1 (0.53) NPC1MEN1KMT2ATP53RAB9A
SCHEMBL4235377 0.86 NPC1 (0.46) NPC1MEN1KMT2ATP53RAB9A
SCHEMBL1747989 0.84 MEN1 (0.50) NPC1MEN1KMT2ARAB9ASMN1; SMN2
SCHEMBL4226578 0.84 NPC1 (0.60) NPC1MEN1KMT2ARAB9ASMN1; SMN2
SCHEMBL5068844 0.84 NPC1 (0.60) NPC1MEN1KMT2ARAB9ASMN1; SMN2
SCHEMBL1748000 0.81 MEN1 (0.47) NPC1MEN1KMT2ARAB9ASMN1; SMN2
SCHEMBL6031201 0.81 MEN1 (0.47) NPC1MEN1KMT2ARAB9ASMN1; SMN2
SCHEMBL4233738 0.81 MAPT (0.54) NPC1MEN1KMT2ARAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1874317-A2 PREPARATION AND USE OF ARYL ALKYL ACID DERIVATIVES FOR THE TREATMENT OF OBESITY Bayer Pharmaceuticals Corporation (US) 2008-01-09 EP disclosed
WO-2006113919-A2 ARYL ALKYL ACID DERIVATIVES FOR AND USE THEREOF BAYER PHARMACEUTICALS CORPORATION (US) 2006-10-26 WO disclosed